Wockhardt gets CDSCO nod for exporting up to 100 million doses of Sputnik Vaccines

Wockhardt Limited, a global Pharmaceutical and Biotechnology Company headquartered in India, on Tuesday said that it has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine.

Wockhardt's Bulk vaccine and Fill-Finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly inspected and approved by Drug inspectors from CDSCO (West zone) & Aurangabad State FDA and Expert from CDL Kasauli to receive export NOC.

Wockhardt's state-of-the-art automated manufacturing facilities in Aurangabad are dedicated to produce world class high quality injectable products.

Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against COVID-19 based on the technology transfer from Gamaleya National Research Institute of Epidemiology and Microbiology.

Shares of Wockhardt Limited was last trading in BSE at Rs. 388.05 as compared to the previous close of Rs. 394.80. The total number of shares traded during the day was 23458 in over 751 trades.

The stock hit an intraday high of Rs. 395.80 and intraday low of 386.50. The net turnover during the day was Rs. 9142123.00.

Source : Equity Bulls

Keywords

Wockhardt INE049B01025 WOCKPHARMA CDSCO Export SputnikLight SputnikVComponentIVaccine Covid19